共 50 条
- [3] Cost-Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma [J]. ONCOLOGIST, 2018, 23 (02): : 225 - 233
- [5] Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19): : 1856 - 1867